Biohit Oyj B (BIOBV) — Capital Reinvestment Ratio
Latest as of December 2025:
0.67x
Biohit Oyj B (BIOBV) has a Capital Reinvestment Ratio of 0.67x as of December 2025, meaning it reinvests 1% of its operating cash flow (€600.00K) in capital expenditures (€400.00K). Check Biohit Oyj B tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
0.67x
Capex / Operating Cash Flow
Operating Cash Flow
€600.00K
EUR
Capital Expenditures
€400.00K
EUR
Data as of
Dec 2025
Most recent filing
Biohit Oyj B Capital Reinvestment Ratio (2000–2024)
This chart tracks Biohit Oyj B's Capital Reinvestment Ratio across 15 annual periods. For the full cash flow conversion analysis, see BIOBV operating cash flow.
Annual Capital Reinvestment Ratio for Biohit Oyj B (2000–2024)
Year-by-year Capital Reinvestment Ratio for Biohit Oyj B from 2000 to 2024. See BIOBV FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.68x | €586.00K | €400.00K | ▲ +148.3% |
| 2023 | 0.27x | €902.00K | €248.00K | ▲ +761.2% |
| 2022 | 0.03x | €1.85 Million | €59.00K | ▼ -94.2% |
| 2019 | 0.55x | €83.00K | €46.00K | ▼ -32.5% |
| 2011 | 0.82x | €4.96 Million | €4.07 Million | ▼ -9.5% |
| 2010 | 0.91x | €1.96 Million | €1.78 Million | ▲ +25.5% |
| 2009 | 0.72x | €2.80 Million | €2.02 Million | ▼ -30.1% |
| 2008 | 1.03x | €1.19 Million | €1.23 Million | ▼ -47.9% |
| 2007 | 1.98x | €1.04 Million | €2.06 Million | ▼ -89.0% |
| 2006 | 17.96x | €100.00K | €1.80 Million | ▲ +546.8% |
| 2005 | 2.78x | €605.00K | €1.68 Million | ▲ +191.8% |
| 2004 | 0.95x | €2.24 Million | €2.13 Million | ▼ -28.1% |
| 2003 | 1.32x | €863.00K | €1.14 Million | ▲ +14.4% |
| 2001 | 1.16x | €1.88 Million | €2.17 Million | ▼ -78.4% |
| 2000 | 5.36x | €5.34 Million | €28.63 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow